ClinicalTrials.gov
public full text
Public Domain
Fasting Study of Olanzapine Tablets 20 mg and Zyprexa® Tablets 20 mg
The objective of this study was to investigate the bioequivalence of Mylan olanzapine 20 mg tablets to Eli Lilly Zyprexa® 20 mg tablets following a single, oral 20 mg (1 x 20 mg) dose administration under fasting conditions.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Bioequivalence Trial of Alprazolam 2 mg Tablets#893842
- Bioequivalence Trial of Alprazolam 0.5 mg Tablets#1139277
- A Relative Bioavailability Study of 2 mg Alprazolam OD Tablets Under Fasting Conditions#889048
- Bioequivalence Study of Naproxen Sodium 550 mg Tablets Under Fasting Condition#891366
- Pantoprazole Sodium 40 mg DR Tablets Under Non-Fasting Conditions#810937
Record · ID 891502
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive